Contact Us
Drug Search Results
More Filters [+]

Dipotassium clorazepate

Alternative Names: dipotassium clorazepate, clorazepate, clorazepate dipotassium, clorazepato, tranxene, gen-xene, tranxene sd, tranxene t-tab
Latest Update: 2024-10-26
Latest Update Note: Clinical Trial Update

Product Description

Clorazepate is used to relieve symptoms of anxiety and alcohol withdrawal. It is also used with other medicines to treat partial seizures. Clorazepate is a benzodiazepine. Benzodiazepines belong to the group of medicines called central nervous system (CNS) depressants, which are medicines that slow down the  (Sourced from: https://www.mayoclinic.org/drugs-supplements/clorazepate-oral-route/side-effects/drg-20072306?p=1)

Mechanisms of Action: GABA Modulator,GABA Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous,Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Algeria | Argentina | Australia | Belgium | Bulgaria | Canada | Chile | Colombia | Dominican Republic | France | Greece | Ireland | Israel | Italy | Lithuania | Luxembourg | Morocco | Netherlands | Pakistan | Peru | Philippines | Poland | Portugal | Slovenia | Spain | Switzerland | Taiwan | Thailand | Tunisia | Turkey | United Kingdom | United States | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: MIKEL URRETAVIZCAYARACHAGA
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Dipotassium clorazepate

Countries in Clinic:

Active Clinical Trial Count: 1

Highest Development Phases

Phase 3: Breastfeeding|Headache

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
CLORMIG

P3

Active, not recruiting

Headache|Breastfeeding

2024-02-12

Recent News Events

Date

Type

Title

07/12/2022

News Article

 Neuraxpharm to increase branded business through upcoming acquisition of established products from Sanofi

06/22/2022

News Article

 ANI Pharmaceuticals Announces FDA Approval and Imminent Launch of Clorazepate Dipotassium Tablets USP

10/30/2020

News Article

 Advisory - Updates to safety labelling for benzodiazepines and benzodiazepine-like drugs

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions